Mutant PIK3CA controls DUSP1-dependent ERK 1/2 activity to confer response to AKT target therapy
突变体 PIK3CA 控制 DUSP1 依赖的 ERK 1/2 活性以产生对 AKT 靶向治疗的反应
期刊:British Journal of Cancer
影响因子:6.4
doi:10.1038/bjc.2014.534
A Sathe, F Guerth, M V Cronauer, M M Heck, M Thalgott, J E Gschwend, M Retz, R Nawroth
